# XTL Biopharmaceuticals Ltd: Form 6-K, filed Aug 10, 2023

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2023-08-10
- Accepted by EDGAR: Aug 10, 2023, 13:30 ET
- Period: 2023-08-10
- Accession: 0001213900-23-065316
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000121390023065316/ea182824-6k_xtlbiopharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000121390023065316/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000121390023065316/ea182824-6k_xtlbiopharma.htm

Filed Aug 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-065316. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
